Copyright: ©Author(s) 2026.
World J Cardiol. Sep 26, 2026; 18(9): 124786
Published online Sep 26, 2026. doi: 10.4330/wjc.124786
Published online Sep 26, 2026. doi: 10.4330/wjc.124786
Table 1 Baseline characteristics of patients with acute heart failure stratified by in-hospital mortality, n (%)/mean ± SD
| Variable | Patients (n = 123) | Survivors (n = 103) | Non-survivors (n = 20) | P value |
| Age (years) | 71.34 ± 13.98 | 70.3 ± 14.34 | 76.4 ± 10.85 | 0.039 |
| Male sex | 62 (50.4) | 52 (50.4) | 10 (50) | 0.968 |
| Smoking | 28 (22.76) | 26 (25.24) | 2 (10) | 0.137 |
| Hypertension | 107 (86.99) | 91 (88.34) | 16 (80) | 0.31 |
| Obesity | 49 (39.83) | 37 (35.92) | 12 (60) | 0.044 |
| Dyslipidaemia | 113 (91.86) | 98 (95.14) | 15 (75) | 0.003 |
| Diabetes mellitus | 49 (39.83) | 40 (38.83) | 9 (45) | 0.606 |
| AF/atrial flutter | 56 (45.52) | 46 (44.66) | 10 (50) | 0.661 |
| ADHF | 100 (81.3) | 86 (83.49) | 14 (70) | 0.157 |
| APE | 23 (18.69) | 17 (16.51) | 6 (30) | 0.157 |
| Cardiogenic shock | 11 (8.94) | 3 (2.91) | 8 (40) | < 0.001 |
| Leg oedema | 73 (59.34) | 58 (56.31) | 15 (75) | 0.119 |
| Pleural effusion | 27 (21.95) | 16 (15.53) | 11 (55) | < 0.001 |
| Ascites | 5 (4.06) | 3 (2.91) | 2 (10) | 0.142 |
| Pulmonary rales | 73 (59.34) | 56 (54.36) | 17 (85) | 0.011 |
| Jugular vein distension | 56 (45.53) | 41 (39.81) | 15 (75) | 0.003 |
| SaO2 | 93.2 ± 5.24 | 93.94 ± 4.16 | 89.8 ± 8.24 | 0.04 |
| SBP (mmHg) | 142.59 ± 29.54 | 144.33 ± 27.43 | 133.6 ± 38.226 | 0.244 |
| DBP (mmHg) | 85.83 ± 16.68 | 87.84 ± 15.747 | 75.45 ± 17.91 | 0.002 |
| Heart rate (bpm) | 100.98 ± 28.12 | 101.5 ± 29.18 | 98.3 ± 22.32 | 0.644 |
| LVEF (%) | 41.21 ± 16.78 | 41.15 ± 16.58 | 41.5 ± 18.23 | 0.934 |
| Haemoglobin (g/dL) | 12.78 ± 2.21 | 12.87 ± 2.22 | 12.35 ± 2.19 | 0.338 |
| eGFR (mL/minute/1.73 m2) | 62.98 ± 22.72 | 64.86 ± 22.23 | 53.3 ± 23.33 | 0.037 |
| Blood urea (mg/dL) | 56.94 ± 28.51 | 54.08 ± 27.77 | 71.38 ± 28.48 | 0.013 |
| Serum sodium (mmol/L) | 137.12 ± 4.6 | 137.54 ± 4.1 | 134.95 ± 6.56 | 0.103 |
| Serum potassium (mmol/L) | 4.31 ± 0.73 | 4.32 ± 0.73 | 4.25 ± 0.79 | 0.682 |
| NT-proBNP (pg/mL) | 9228.3 ± 9736.4 | 7569.6 ± 8565.9 | 17770.8 ± 11093.4 | 0.001 |
| pH | 7.38 ± 0.07 | 7.39 ± 0.07 | 7.34 ± 0.06 | 0.002 |
| PaO2 (mmHg) | 65.72 ± 30.14 | 68.59 ± 31.5 | 50.95 ± 15.22 | < 0.001 |
| PaCO2 (mmHg) | 33.47 ± 8.48 | 32.69 ± 8.54 | 37.5 ± 7.07 | 0.011 |
| Lactate (mmol/L) | 2.31 ± 1.59 | 2.11 ± 1.47 | 3.35 ± 1.83 | 0.009 |
Table 2 Penalized multivariable logistic regression model for in-hospital mortality
| Variable | β-coefficient | OR | 95%CI | P value |
| Log (NT-proBNP) | 0.74 | 2.10 | 1.30-3.42 | 0.002 |
| Lactate (mmol/L) | 0.42 | 1.52 | 1.10-2.09 | 0.011 |
| Serum sodium (per mmol/L decrease) | -0.15 | 0.86 | 0.77-0.96 | 0.007 |
| SBP < 100 mmHg (yes vs no) | 0.91 | 2.48 | 1.18-5.20 | 0.017 |
| Congestion index (0-4) | 0.55 | 1.73 | 1.22-2.45 | 0.002 |
Table 3 Fast Assessment Score for triage in heart failure bedside score: Predictors, categories and assigned points
| Predictor | Category | Points |
| NT-proBNP (pg/mL) | < 3000 | 0 |
| 3000-8000 | 3 | |
| > 8000 | 5 | |
| Lactate (mmol/L) | < 2 | 0 |
| 2-4 | 2 | |
| > 4 | 3 | |
| Serum sodium (mmol/L) | ≥ 135 | 0 |
| 130-134 | 2 | |
| 125-129 | 4 | |
| < 125 | 6 | |
| SBP (mmHg) | ≥ 100 | 0 |
| < 100 | 6 | |
| Congestion index (0-4) | 0 | 0 |
| 1 | 4 | |
| 2 | 8 | |
| 3 | 12 | |
| 4 | 16 | |
| Total | 36 points |
Table 4 Observed in-hospital mortality across bedside score risk categories
| Risk group | FAST-HF Score range | n | Mortality (%) |
| Low risk | 0-8 | 39 | 0.0 |
| Intermediate risk | 9-14 | 40 | 7.5 |
| High risk | ≥ 15 | 44 | 38.6 |
Table 5 Comparison of prognostic score performance for in-hospital mortality
| Score | AUC | 95%CI | P value |
| FAST-HF | 0.867 | 0.784-0.936 | < 0.001 |
| EHMRG | 0.720 | 0.571-0.856 | 0.012 |
| GWTG-HF | 0.619 | 0.444-0.776 | 0.085 |
- Citation: Diaconu M, Popescu DC, Țînț D, Nechita AC. Development and internal validation of a rapid bedside score for predicting in-hospital mortality in acute heart failure. World J Cardiol 2026; 18(9): 124786
- URL: https://www.wjgnet.com/1949-8462/full/v18/i9/124786.htm
- DOI: https://dx.doi.org/10.4330/wjc.124786